CathWorks FFRangio™ System Receives U.S. FDA Clearance

KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announces U.S. FDA clearance of the CathWorks FFRangio System for objective FFR guidance needed to optimize PCI therapy decisions.

Source link